Electrocatalytic reductive deuteration of arenes and heteroarenes.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 39208847.
- Also identified by DOI 10.1038/s41586-024-07989-7.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The incorporation of deuterium in organic molecules has widespread applications in medicinal chemistry and materials science<sup>1,2</sup>. For example, the deuterated drugs austedo<sup>3</sup>, donafenib<sup>4</sup> and sotyktu<sup>5</sup> have been recently approved. There are various methods for the synthesis of deuterated compounds with high deuterium incorporation<sup>6</sup>. However, the reductive deuteration of aromatic hydrocarbons-ubiquitous chemical feedstocks-to saturated cyclic compounds has rarely been achieved. Here we describe a scalable and general electrocatalytic method for the reductive deuteration and deuterodefluorination of (hetero)arenes using a prepared nitrogen-doped electrode and deuterium oxide (D<sub>2</sub>O), giving perdeuterated and saturated deuterocarbon products. This protocol has been successfully applied to the synthesis of 13 highly deuterated drug molecules. Mechanistic investigations suggest that the ruthenium-deuterium species, generated by electrolysis of D<sub>2</sub>O in the presence of a nitrogen-doped ruthenium electrode, are key intermediates that directly reduce aromatic compounds. This quick and cost-effective methodology for the preparation of highly deuterium-labelled saturated (hetero)cyclic compounds could be applied in drug development and metabolism studies.
Medical subject headings
- Chemistry Techniques, Synthetic
- Deuterium Oxide
- Electrochemistry
- Electrodes
- Nitrogen
- Pharmaceutical Preparations
- Ruthenium